Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,239 total articles
Arch Capital (ACGL) has pulled back into the mid-$90s on heavy volume and short-selling, but fundamentals - low leverage, strong free cash flow ($6.295B), and attractive valuation (PE ~8.6, P/B ~1.47) - argue for a tactical long. This trade idea lays out an entry at $96.03, a stop at $86.00 and a primary target of $110.00 over a 180-trading-day hor…
WPP is trading at bargain multiples after a painful share-price correction. At $18.66 the stock carries an elevated yield and single-digit P/E that imply free-cash-flow generosity; combine that with secular digital ad growth and the potential for operational stabilization and you have an asymmetric trade. This is a long idea with a defined entry, s…
DBS Group (DBSDY) offers a balanced trade: a reliable dividend (3.7% yield), a sensible P/E (~15.8) and exposure to Asia's recovery. Technicals are mixed but constructive; we lay out an entry at $183.09, a $205 target and a $170 stop for a long-term (180 trading days) swing that captures both income and capital appreciation.
CrowdStrike (CRWD) remains the market leader in cloud-native endpoint and workload protection. After a pullback that left technical indicators oversold, the stock offers a better entry for traders who want exposure to high-growth cybersecurity without paying peak multiples. This trade idea lays out an actionable mid-term long: entry at the current …
Medpace reported robust growth and cash flow, but the stock is trading at a premium (PE ~36, EV/EBITDA ~28) after a strong rerating. With technicals weak and evidence that bookings/backlog are not accelerating enough to justify the multiple, a structured short against $535 with a $460 target over the next 45 trading days offers a defined risk/rewar…
Cenovus ($CVE) completed the MEG Energy acquisition and added ~110,000 bbl/d of low-cost oil sands production. The company is guiding modest 2026 upstream growth, has a refreshed buyback program, and is refinancing debt. Technical momentum is bullish. This trade idea buys the name on strength with a defined stop and a clear mid-term horizon tied to…
Genworth is trading at steep discounts to book and to obvious intrinsic components. Enact mortgage insurance continues to generate earnings and capital returns while long‑term care exposure is de‑risking through rate actions. With a market cap near $3.55B, EV of roughly $3.09B and EV/EBITDA under 4, this is a deep‑value sum‑of‑the‑parts opportunity…
Allegiant's cost-focused model and the accretive Sun Country deal give the stock a clear re-rating path. Catalyst-driven swing trade with defined entry, stop and target: capture merger optimism, early synergy proof points and continued leisure demand while respecting balance-sheet and valuation risks.
Dominion Energy is uniquely exposed to Virginia's data-center boom and is pressing forward on the Coastal Virginia Offshore Wind (CVOW) project despite a short-lived federal review. The business mix, dividend yield, and reasonable valuation support a measured long trade over the next 45 trading days while watching regulatory signals and cash-flow m…
Intuit has been punished with the rest of software as investors fear AI will replace SaaS economics. The selloff has left a high-quality franchise trading at roughly half its 52-week high, with healthy free cash flow, low net leverage, and an oversold technical picture. This trade idea grades Intuit attractive now for a position trade with explicit…
Solid Biosciences looks positioned to re-rate after a positive FDA interaction on SGT-003 and a string of regulatory wins for the gene-therapy space. With a market cap near $533M, manageable enterprise value and clear catalysts ahead, we prefer a tactical long with defined risk control.
Hims & Hers (HIMS) plunged to 52-week lows after an FDA crackdown and a patent suit from Novo Nordisk over compounded semaglutide pills. The sell-off created a high-conviction trade: buy the oversold dip around $19.33 with a tight stop under the intraday low and a mid-term target near $28. The company still has a $4.4B market cap, positive free cas…
Novo Nordisk (NVO) has been hit hard after weaker 2026 guidance and a U.S. pricing deal, but its GLP-1 demand and new oral pill adoption give a clear rebound scenario. This trade idea lays out a mid-term swing entry, explicit stop and target levels, catalysts to watch, and the risks that could invalidate the trade.
Patterson-UTI (PTEN) trades like a capital-return vehicle more than a growth story. With $289M in free cash flow, an EV/EBITDA of 4.6, a dividend yield near 3.7% and a large remaining repurchase authorization, the company can choose to buy back stock or sustain the dividend instead of chasing higher-risk diversification. The trade: go long for a mi…
Shares of LKQ Corporation have pulled back into the low $30s after a rough 2025 and index reweighting. The combination of solid free cash flow ($722M), a 3.5% yield, delevered balance sheet (debt/equity 0.63), and an active sale process for the Specialty segment creates a near-term catalyst-rich setup. I propose a mid-term swing trade to capture a …
The Walt Disney Company is cheaper than it has been in years on a variety of metrics, just turned streaming profitable, and is deploying a $7 billion buyback while leaning into high-margin parks and experiences. With a market cap near $190B, a forward P/E around 16 and free cash flow north of $7B, DIS presents an asymmetric risk/reward. I rate it S…
SoFi reported accelerated revenue growth and profitability in Q4 2025 and has optionality across lending, payments and banking. At roughly $26.9B market cap and a current price near $21.38, the stock looks mispriced relative to a plausible re-rate as revenue and EPS expand. This trade idea outlines a mid-term long with a defined entry, stop and tar…
PayPal (PYPL) has been punished hard after weak Q4 results, a profit warning and a CEO transition. The stock trades near its 52-week low, with a P/FCF around 6.7, free cash flow of $5.56B and an enterprise value under $40B. Technicals are brutally oversold and short interest is moderate - a setup for a value-driven bounce. This trade idea lays out …
Mitsubishi Heavy Industries (MHVYF) shows clear technical strength, elevated short interest and recent buy-side narrative that together support a bullish position. Enter around $32.00 with a $29.00 stop and a $38.00 target for a position intended to run through potential full-year upside over the next 3-6 months.
KSA (iShares MSCI Saudi Arabia ETF) looks positioned for a long-term trade: attractive yield (3.41%), reasonable valuation (P/E ~16.7), and technical momentum near the 20/50-day EMAs. We recommend a long trade with clear entry, stop and a target near the 52-week high, balanced by geopolitics and commodity-risk considerations.
Nordic American Tankers (NAT) trades near $4.25 with a market cap under $900M, an 8.45% dividend yield and recent fleet additions that should support cash flow. Technicals show the stock near a 52-week high while volume and insider buying add conviction. This trade idea lays out an actionable long entry with a clear stop and target and a rationale …
Amazon's share price has pulled back on heavy 2026 AI infrastructure spending headlines, but the selloff creates a targeted long-term opportunity. AWS's $142B revenue run rate and 24% growth plus immediate monetization of new capacity argue for patience. Trade plan: enter at $205.00, stop $190.00, target $260.00 over a 180-trading-day horizon.
CrowdStrike (CRWD) has retraced roughly 30% from its 52-week high while retaining strong growth, solid free cash flow, and a conservative balance sheet. Technicals show oversold conditions and short interest that can fuel a squeeze. I’m upgrading to Buy with a clear entry, stop and target for a mid-term swing trade.
PayPal plunged after a weak quarter and lowered guidance, but the sell-off appears overextended. Balance-sheet strength, meaningful free cash flow and single-digit valuation create an asymmetric risk/reward for a mid-term (45 trading days) long trade. This is a tactical trade, not a statement that all operational issues are solved.
Crown Holdings' sizable free cash flow and solid return on equity support a buy-rated trade. Valuation metrics - P/E ~13.5, EV/EBITDA ~11.7 and price/free cash flow ~12.7 - leave room for a re-rating if commodity costs stabilize and beverage demand holds. Technicals and dividend support create a favorable entry around $110 with a clear stop under n…
